Stockscreener 앱 받기
15.62
6.30%
-1.05
시간 외 거래:
15.62
전일 마감가:
$16.67
열려 있는:
$16.55
하루 거래량:
172.07K
Relative Volume:
0.52
시가총액:
$291.51M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-16.25%
1개월 성능:
-32.47%
6개월 성능:
-52.70%
1년 성능:
+0.00%
1일 변동 폭
$15.20
$16.55
1주일 범위
$15.20
$18.64
52주 변동 폭
$15.00
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
명칭
Tectonic Therapeutic Inc
전화
(339) 666-3320
주소
490 ARSENAL WAY, WATERTOWN
TECX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
15.62 | 291.51M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-20 | 개시 | Raymond James | Outperform |
| 2024-08-22 | 개시 | Wells Fargo | Overweight |
| 2024-06-26 | 개시 | Piper Sandler | Overweight |
| 2024-06-24 | 개시 | TD Cowen | Buy |
| 2023-12-18 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-05 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-05-27 | 개시 | Needham | Buy |
| 2021-03-09 | 개시 | Barclays | Overweight |
| 2021-03-02 | 개시 | Stifel | Hold |
| 2020-11-11 | 개시 | Berenberg | Buy |
| 2020-03-31 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | 개시 | Mizuho | Buy |
| 2019-04-05 | 개시 | Janney | Buy |
| 2018-10-10 | 개시 | Guggenheim | Buy |
| 2018-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-17 | 개시 | H.C. Wainwright | Buy |
| 2018-07-16 | 개시 | Wedbush | Outperform |
| 2018-07-16 | 개시 | Wells Fargo | Outperform |
모두보기
Tectonic Therapeutic Inc 주식(TECX)의 최신 뉴스
Tectonic Therapeutic Reports Strong 2024 Financial Results - TipRanks
Charles Schwab Investment Management Inc. Invests $218,000 in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Receives $77.75 Average Price Target from Brokerages - Defense World
Tectonic Therapeutic: Buy Rating Affirmed on Strong Financials and Promising Pipeline - TipRanks
Wells Fargo & Company Lowers Tectonic Therapeutic (NASDAQ:TECX) Price Target to $101.00 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Given New $101.00 Price Target at Wells Fargo & Company - Armenian Reporter
Tectonic Therapeutic Inc. (TECX) reports earnings - Quartz
Tectonic Therapeutic Announces Fourth Quarter And Full Year 2024 Financial Results And Recent Business Highlights - Marketscreener.com
Tectonic Therapeutic Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Tectonic Therapeutic, Inc. SEC 10-K Report - TradingView
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic's TX45 Trial Achieves 30% Disease Reduction, Extends Runway to 2028 - StockTitan
Tectonic Therapeutic Inc expected to post a loss of $1.39 a shareEarnings Preview - TradingView
Tectonic Therapeutic director Timothy Springer buys $39.9 million in stock - MSN
Tectonic Therapeutic (TECX) Expected to Announce Quarterly Earnings on Thursday - Defense World
Is Tectonic Therapeutic, Inc. (TECX) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey
10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Price Target at $80.50 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Given Average Rating of "Buy" by Brokerages - MarketBeat
Tectonic Therapeutic, Inc. (TECX): Among the Most Expensive Stocks Insiders Are Buying Recently - Insider Monkey
11 Most Expensive Stocks Insiders Are Buying Recently - Insider Monkey
Tectonic Therapeutic to Participate in March Investor Conferences - The Manila Times
Exclusive Access: Tectonic's Management Team Opens Door to Investors at Major March Conferences - StockTitan
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short Interest - MarketBeat
Fresh Tracks Therapeutics (NASDAQ:FRTX) vs. Tectonic Therapeutic (NASDAQ:TECX) Head to Head Comparison - Armenian Reporter
Analyzing Fresh Tracks Therapeutics (NASDAQ:FRTX) and Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic jumps on positive data from early-stage trial for lead asset - MSN
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up Following Insider Buying Activity - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Director Timothy A. Springer Buys 129,294 Shares - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 3.2%Should You Sell? - MarketBeat
Daniel Lochner Acquires 4,617 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - MarketBeat
Contrasting Tectonic Therapeutic (NASDAQ:TECX) and Vir Biotechnology (NASDAQ:VIR) - Defense World
Major Stock Purchases Signal Strong Confidence in Tectonic Therapeutic! - TipRanks
Tectonic Therapeutic Inc (TECX) Stock: A Review of the Recent Movement - The News Heater
Petri Dish: VC firm's new $340M seed fund; Watertown biotech raises $185M - The Business Journals
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $80.50 - Defense World
Tectonic announces ~$185M capital raise - MSN
Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data (NASDAQ:TECX) - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Given New $112.00 Price Target at Wells Fargo & Company - MarketBeat
TECX (Tectonic Therapeutic Inc) may reap gains as insiders became active recently - Knox Daily
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Up 6.7% Following Analyst Upgrade - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Reaches New 52-Week HighTime to Buy? - MarketBeat
Tectonic secures $185 million in private equity funding - MSN
Tectonic Therapeutic Inc (TECX) 재무 분석
Tectonic Therapeutic Inc (TECX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.01%
자본화:
|
볼륨(24시간):